Picture of Immutep logo

IMM — Immutep News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Immutep Announces Initiation Of Investigator-Initiated Phase Ii Trial In Soft Tissue Sarcoma In Neoadjuvant Setting

April 17 (Reuters) - Immutep Ltd  IMM.AX :
    * IMMUTEP ANNOUNCES INITIATION OF INVESTIGATOR-INITIATED
PHASE II
TRIAL IN SOFT TISSUE SARCOMA IN NEOADJUVANT SETTING

Source text for Eikon:  ID:nGNX1gZF4d 
Further company coverage:  IMM.AX

Recent news on Immutep

See all news